OLPHARM NIGERIA Ltd.

Pharma / Medical
  • Lagos, Nigeria

Africa Pharmaceutical Directory

OLPHARM NIGERIA Ltd.

Pharma / Medical

Lagos, Nigeria

OLPHARM NIGERIA LIMITED is a healthcare company with a team of fully qualified Managers, Pharmacists and other Professionals, with presence in major cities and towns in Nigeria.

Our strategy of dealing with specialist medical practitioners and major wholesalers/distributors all over the country has made OLPHARM NIGERIA LIMITED's name a household within the product segment we have been dealing on.

Today, we are among leaders in Malarial drugs with full baskets of oral and injectable formulations and leader in kidney products marketing machines, accessories and consumables.

In 2010, we signed a contract with WHO / Global Fund as major supplier of Pre-qualified anti-malaria products in Nigeria.

The company began as a retail pharmacy whose goal was to build a pharmaceutical company in Nigeria that would meet the needs of the local population, West African sub-region and would also develop an international presence through importation of good quality finished pharmaceutical products and local manufacturing from our own plant.

Since inception, we have been engaged in local distribution and sales of a wide range of healthcare products, from Over-The-Counter (OTC) preparations to specialty pharmaceutical products, for multinational companies in India, United Kingdom, USA, Germany, China and France.

Our strategy of dealing with specialist medical practitioners and major wholesalers/distributors all over the country has made OLPHARM NIGERIA LIMITED's name a household within the product segment we have been dealing on.

Our client base includes but not limited to:

  • Federal and State Ministry of Health – Federal Government and State Governments;
  • Teaching/Specialist Hospitals;
  • General Hospitals;
  • Private Clinics;
  • Wholesale and Retail Pharmacies;
  • Government Parastatals and Private individuals; and
  • West African Neighbouring Countries.

We are proud of our journey so far, and anticipate further growth in the exiting years ahead.

Contact this Company

=